Lansdowne Partners, founded in 1998, is a venture capital fund that invests in Series A and B rounds, focusing on quantum computing and health tech. They support companies like Genomics and Oxford Ionics, providing essential funds for growth. Lansdowne Partners manages assets for some of the world's largest and most experienced investors, helping to bring advanced technologies to market.
